A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT02116582 · COMPLETED
Trial details
- NCT number
- NCT02116582
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-23
- Primary completion
- 2016-05-08
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.